PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM
Total 13F shares
18,469,511
Share change
-914,921
Total reported value
$61,110,981
Price per share
$3.31
Number of holders
48
Value change
-$3,921,637
Number of buys
21
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q1 2020

As of 31 Mar 2020, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,469,511 shares. The largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Johnson & Johnson Innovation - JJDC, Inc., Rock Springs Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Ghost Tree Capital, LLC, DAFNA Capital Management LLC, and STATE STREET CORP. This page lists 48 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.